Autodesk Maya, Adobe After Effects

The purpose of this animation is to build upon the raised awareness surrounding the discrepancy that exists between EpiPen manufacturing costs and EpiPen price sold to the public. In an effort to maximize profits, the company that manufactures the EpiPen has increased the consumer cost of the lifesaving device nearly tenfold since 2007 while actual manufacturing costs associated with EpiPen components has remained relatively consistent over the course of that same time. Due to a lack of competition, device effectiveness, and overall success of the EpiPen, which was introduced in 1977, the EpiPen manufacturer began to aggressively raise the price sold to the public between 2007 and 2008. While the company insists that through insurance, individuals have not actually seen any drastic change in price during this same time period, critics contend that cost increase has actually been passed directly to consumers by other means through their insurance providers over that same time. In addition, those without insurance coverage have now been completely priced out which only acts to further the existing divisions within healthcare between price and accessibility.